Literature DB >> 32770188

Leptomeningeal metastases: how best to assess response.

Marc C Chamberlain.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32770188      PMCID： PMC7566394          DOI： 10.1093/neuonc/noaa184

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  5 in total

Review 1.  Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee.

Authors:  Katherine E Warren; Gilbert Vezina; Tina Y Poussaint; Monika Warmuth-Metz; Marc C Chamberlain; Roger J Packer; Alba A Brandes; Moshe Reiss; Stewart Goldman; Michael J Fisher; Ian F Pollack; Michael D Prados; Patrick Y Wen; Susan M Chang; Christelle Dufour; David Zurakowski; Rolf D Kortmann; Mark W Kieran
Journal:  Neuro Oncol       Date:  2018-01-10       Impact factor: 12.300

2.  The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposal.

Authors:  Emilie Le Rhun; Patrick Devos; Thomas Boulanger; Marion Smits; Dieta Brandsma; Roberta Rudà; Julia Furtner; Johann-Martin Hempel; Tjeerd J Postma; Patrick Roth; Tom J Snijders; Frank Winkler; Sebastian Winklhofer; Antonella Castellano; Elke Hattingen; Jaume Capellades; Thierry Gorlia; Martin Van den Bent; Patrick Y Wen; Martin Bendszus; Michael Weller
Journal:  Neuro Oncol       Date:  2019-05-06       Impact factor: 12.300

Review 3.  Leptomeningeal metastases: a RANO proposal for response criteria.

Authors:  Marc Chamberlain; Larry Junck; Dieta Brandsma; Riccardo Soffietti; Roberta Rudà; Jeffrey Raizer; Willem Boogerd; Sophie Taillibert; Morris D Groves; Emilie Le Rhun; Julie Walker; Martin van den Bent; Patrick Y Wen; Kurt A Jaeckle
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

Review 4.  The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria.

Authors:  Lakshmi Nayak; Lisa M DeAngelis; Alba A Brandes; David M Peereboom; Evanthia Galanis; Nancy U Lin; Riccardo Soffietti; David R Macdonald; Marc Chamberlain; James Perry; Kurt Jaeckle; Minesh Mehta; Roger Stupp; Alona Muzikansky; Elena Pentsova; Timothy Cloughesy; Fabio M Iwamoto; Joerg-Christian Tonn; Michael A Vogelbaum; Patrick Y Wen; Martin J van den Bent; David A Reardon
Journal:  Neuro Oncol       Date:  2017-05-01       Impact factor: 12.300

5.  Evaluation of RAPNO criteria in medulloblastoma and other leptomeningeal seeding tumors using MRI and clinical data.

Authors:  Jian Peng; Hao Zhou; Oliver Tang; Ken Chang; Panpan Wang; Xiaowei Zeng; Qin Shen; Jing Wu; Yanhe Xiao; Sohil H Patel; Chongyu Hu; Ke Jin; Bo Xiao; Jerrold Boxerman; Xiaoping Gao; Patrick Y Wen; Harrison X Bai; Raymond Y Huang; Li Yang
Journal:  Neuro Oncol       Date:  2020-10-14       Impact factor: 12.300
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.